A new study conducted by Quest Diagnostics in collaboration with the University of Alabama has revealed significant gaps in the testing and treatment of sexually transmitted infections (STIs) among pregnant women in the United States. The study, titled Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations, was published in the ‘Journal of Lower Genital Tract Disease’ and…
The National Institutes of Health (NIH) has announced a new initiative aimed at accelerating the development of non-invasive technologies for diagnosing endometriosis, a chronic condition that affects approximately 10% of reproductive-aged women worldwide. The RADx Tech ACT ENDO Challenge, co-led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Biomedical Imaging and…
Needed, a company dedicated to improving perinatal nutrition, has launched Needed Academy, an Instagram-based educational program designed to address the critical need for accurate information on fertility, pregnancy, and postpartum health. Needed Academy is an educational platform specifically created for health practitioners, advocates, and influencer partners associated with Needed. The program responds to the widespread issue of outdated and inaccurate health information…
The new AI-powered Feeling Great app has raised $8 million in seed funding to bring innovative mental health care solutions to users worldwide. This funding round was co-led by Learn Capital and TitleTownTech, with additional participation from Lux Ventures, WaveMaker Three-Sixty Health, Pacific Health Ventures, and Treble Capital. Developed by Dr. David D. Burns, a renowned psychiatrist and best-selling author, along with…
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on novel treatments for severe ischemic diseases, has announced the initiation of a Phase 2 trial for their preeclampsia treatment, DM199. This announcement came alongside their second quarter 2024 financial results and business update. Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure and damage to organ systems, often affecting the kidneys…
Johnson & Johnson has announced significant findings from their Phase 2 UNITY study of nipocalimab for the treatment of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The results, published in The New England Journal of Medicine, indicate that nipocalimab can delay or prevent severe fetal anemia and improve birth outcomes. HDFN occurs…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Afynia Laboratories secures $1.5M to advance endometriosis diagnostics with EndomiR. Noze secures $5M investment from the Gates Foundation for its breath-based disease detection technology. WellSpring Consumer Healthcare…
Sunny, a self-care brand in menstrual care, has achieved another milestone with their Sunny Cup + Applicator, now the first menstrual cup and applicator to receive FDA 510(k) clearance. This Class II Medical Device addresses the primary barrier preventing tampon users from switching to more sustainable menstrual products, free from potentially harmful materials. Sunny is a queer, women, and BIPOC-owned self-care brand…
